NRX Pharmaceuticals, Inc. Common Stock (NRXP)
NRX Pharmaceuticals, Inc. (NRXP) is a biopharmaceutical company focused on developing innovative therapies for central nervous system and neurodegenerative disorders. The company aims to address unmet medical needs through clinical development and commercialization of novel pharmaceutical products.
Company News
NRx Pharmaceuticals announced that the FDA has granted a filing fee waiver for its upcoming NRX-100 (preservative-free ketamine) New Drug Application to treat suicidal depression. The waiver will enable the company to complete the NDA filing with its current resources.
The latest trading day saw NRx Pharmaceuticals, Inc. (NRXP) settling at $3.14, representing a +0.64% change from its previous close.
Penny stocks under $3 to watch this week. The post 3 Penny Stocks Under $3 To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
A patent-court loss sent investors scurrying to the exits.
RADNOR, Pa., Feb. 11, 2022 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals (Nasdaq: NRXP), a clinical-stage, biopharmaceutical company, today reported remarks by Dr. Shmuel Yitzhaki, Director of the Israel Institute for Biological Research, who spoke at the Eli Hurvitz Institute for Strategic Management of Tel Aviv University. His remarks were summarized in the Hebrew language edition of Globes as follows: